Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02109094 · ClinicalTrials.gov registry record
Investigating Markers of Energy Metabolism in Pregnant Women With Insulin Resistance
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 48
- Enrollment target
NCT02109094 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 48 participants.
The verdict
NCT02109094 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
The investigators seek to examine the metabolic changes that occur amongst obese and lean pregnant women with normal glycemic control as well as pregnant women with diabetes mellitus (gestational diabetes and pre-existing type 2 diabetes mellitus) compared to non-pregnant age matched controls. Given the adaptive tendency of the maternal body to use alternative energy sources such as ketones and free fatty acids rather than glucose and to shunt glucose and amino acids to the fetus, the investigators hypothesize that the amino acid and fatty acid profile will be reflective of this adaptive change and that maternal insulin resistance will result in alterations in this pattern in both the plasma and CSF. Furthermore, the investigators also hypothesize that maternal degrees of insulin resistance will also be reflected in CSF hormonal changes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02109094
The ClinicalTrials.gov registry entry for NCT02109094 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02109094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02109094 about?
NCT02109094 is a clinical study titled "Investigating Markers of Energy Metabolism in Pregnant Women With Insulin Resistance". The investigators seek to examine the metabolic changes that occur amongst obese and lean pregnant women with normal glycemic control as well as pregnant women with diabetes mellitus (gestational diabetes and pre-existing type 2 diabetes mellitus) compared to non-pregnant age matched controls. Given...
What is the current status of trial NCT02109094?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2014-02. Estimated completion is 2015-02.
Who is sponsoring clinical trial NCT02109094?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.